Fine-mapping of the TMEM106B locus identifies four haplotypes with differential associations to neurodegeneration
Abstract
Genetic variation at the TMEM106B locus has been associated with Alzheimers disease (AD) and related neurodegenerative phenotypes, yet the underlying haplotypic architecture remains incompletely resolved. We refined the genetic landscape of TMEM106B by integrating AD GWAS summary statistics (~978K individuals) with haplotype analyses in 5,873 Dutch genomes including AD-cases, age-matched controls, and cognitively healthy centenarians. In addition to the known linkage disequilibrium (LD) block defining risk and protective haplotypes characterized by the amino acid substitution at residue 185 (Threonine/Serine), we identify a second conditionally independent LD block. Together these form four haplotypes (T1-T4), with T3 strongly enriched in centenarians. Long-read whole-genome sequencing in 493 individuals reveals haplotype-specific structural variants, including a ~19 Kbp rearrangement carried by T3. We also observe haplotype-specific DNA methylation patterns. These findings indicate that TMEM106B haplotypes represent coordinated structural and epigenetic states refining GWAS signals associated with AD risk and cognitive longevity.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper identifies four haplotypes at the TMEM106B locus that are associated with neurodegeneration and cognitive longevity. The research explores genetic factors that may contribute to longevity and cognitive resilience, which aligns with the broader goals of understanding aging mechanisms.
Author of this paper? Send a correction.